US Patent 7989585 Chronic treatment regimen using glucagon-like insulinotropic peptides
Patent 7989585 was granted and assigned to Eli Lilly and Company on August, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7989585 Chronic treatment regimen using glucagon-like insulinotropic peptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.